Skip to content

Absci Corporation ABSI Debt-to-assets

Debt-to-assets at other companies

Schrodinger logo
SchrodingerSDGR
0.2×0.0×
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
0.1×0.0×
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
0.0×
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
0.1×+0.1×
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
ADMA Biologics logo
ADMA BiologicsADMA
0.3×+0.3×

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Calculated from Absci Corporation’s reported figures.

Based on the most recent quarter.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's debt-to-assets?
Absci Corporation (ABSI) reported debt-to-assets of 0× in Q1 2026.
How has Absci Corporation's debt-to-assets changed year-over-year?
Absci Corporation's debt-to-assets decreased by 25.2% year-over-year, from 0× to 0×.
What is the long-term trend for Absci Corporation's debt-to-assets?
Over 5 years (2020 to 2025), Absci Corporation's debt-to-assets has grown at a -32.5% compound annual growth rate (CAGR), from 0.1× to 0×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.